Action Required: Password Reset on Next Login
As part of our recent security and system improvements, a password reset will be required the next time you log in. This applies to username/password users only; SSO users are not affected.
To reset your password, please visit the Reset Password page.
We appreciate your patience during this transition and are available to assist with any questions. For support, please call us at +1 650-552-4224 or email us at support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a target name.
BioCentury | Jan 28, 2025
Distillery Therapeutics
Sulfatide-targeting natural killer T cell activation for cardiac arrest-associated neurological injury
BioCentury | Aug 10, 2022
Management Tracks
New CMOs at Arcus, Enanta
Plus Lamba becomes CFO at ImmPACT, and updates from Appia Bio and Quanterix
BioCentury | Sep 18, 2020
Finance
Lava’s $83M series C exemplifies evolution of Novo Ventures’ investing
Danish firm has dramatically increased pace, size of investments
BioCentury | Jun 21, 2018
Translation in Brief
Liver’s killer instinct
NCI study shows why the liver may be able to fight tumors after microbiome depletion
BioCentury | May 16, 2018
Preclinical News
Nanoparticle pretreatment could boost solid tumor CAR T therapy
BioCentury | Feb 8, 2016
Product Development
Asthma armament
How Amgen's AMG 282 fits into Genentech's asthma portfolio
BioCentury | Sep 17, 2015
Finance
NIAAA focuses on developing medicines
NIAAA focuses on developing medicines for alcohol addiction
Items per page:
1 - 10 of 35